Article

Metabolic Regulation in Pluripotent Stem Cells during Reprogramming and Self-Renewal

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Cell stem cell (Impact Factor: 22.27). 11/2012; 11(5):589-95. DOI: 10.1016/j.stem.2012.10.005
Source: PubMed

ABSTRACT

Small, rapidly dividing pluripotent stem cells (PSCs) have unique energetic and biosynthetic demands compared with typically larger, quiescent differentiated cells. Shifts between glycolysis and oxidative phosphorylation with PSC differentiation or reprogramming to pluripotency are accompanied by changes in cell cycle, biomass, metabolite levels, and redox state. PSC and cancer cell metabolism are overtly similar, with metabolite levels influencing epigenetic/genetic programs. Here, we discuss the emerging roles for metabolism in PSC self-renewal, differentiation, and reprogramming.

Full-text preview

Available from: sciencedirect.com
  • Source
    • "For example, Neurogenin2 (Neurog2) efficiently induces neuronal conversion of mouse postnatal astrocytes in culture (Berninger et al., 2007; Blum et al., 2011; Heinrich et al., 2010) but is rather ineffective in mouse embryonic fibroblasts (MEFs) (Chanda et al., 2014) or adult reactive glial cells in vivo (Grande et al., 2013). While the starting cell type may dictate conversion efficiency by providing transcriptional accessibility of target genes (Wapinski et al., 2013), other cellular processes shown to influence reprogramming into induced pluripotent stem cells (iPSCs) such as cell death (Kawamura et al., 2009), proliferation rate (Halley-Stott et al., 2014; Ruiz et al., 2011), or metabolic state (Zhang et al., 2012) may also be important in direct neuronal reprogramming. Among them, the metabolic state is particularly relevant for the conversion into neurons , which rely on oxidative metabolism, while astroglia, fibroblasts, and proliferative cells rather utilize anaerobic glycolysis and b-oxidation (McKay et al., 1983; Tsacopoulos and Magistretti , 1996). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite the widespread interest in direct neuronal reprogramming, the mechanisms underpinning fate conversion remain largely unknown. Our study revealed a critical time point after which cells either successfully convert into neurons or succumb to cell death. Co-transduction with Bcl-2 greatly improved negotiation of this critical point by faster neuronal differentiation. Surprisingly, mutants with reduced or no affinity for Bax demonstrated that Bcl-2 exerts this effect by an apoptosis-independent mechanism. Consistent with a caspase-independent role, ferroptosis inhibitors potently increased neuronal reprogramming by inhibiting lipid peroxidation occurring during fate conversion. Genome-wide expression analysis confirmed that treatments promoting neuronal reprogramming elicit an anti-oxidative stress response. Importantly, co-expression of Bcl-2 and anti-oxidative treatments leads to an unprecedented improvement in glial-to-neuron conversion after traumatic brain injury in vivo, underscoring the relevance of these pathways in cellular reprograming irrespective of cell type in vitro and in vivo.
    Full-text · Article · Dec 2015 · Cell stem cell
    • "For example, certain cells of solid tumors can produce ATP under glucose deprivation conditions [14]. Additionally, certain cancer cell lines can efficiently produce higher than normal amounts of ATP (possibly by developing alternative pathways) although mitochondrial performance has been compromised [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27]. It is well-known that in the case of prolonged mitochondrial dysfunction the nuclear transcriptional activity is drastically changed as cells acquire an alternative metabolic profile and an oncogenic phenotype [12]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent evidence shows that mitochondria regulate nuclear transcriptional activity both in normal and cell stress conditions, known as retrograde signaling. Under normal mitochondrial function, retrograde signaling is associated with mitochondrial biogenesis, normal cell phenotype and metabolic profile. In contrast, mitochondrial dysfunction leads to abnormal (oncogenic) cell phenotype and altered bio-energetic profile (nucleus reprogramming). Despite intense research efforts, a concrete mechanism through which mitochondria determine the group of genes expressed by the nucleus is still missing. The present paper proposes a novel hypothesis regarding retrograde signaling. More specifically, it reveals the mitochondrial membrane potential (MMP) and the accompanied strong electromagnetic field (EF) as key regulatory factors of nuclear activity. Mitochondrial emitted EFs extend in long distance and affect the function of nuclear membrane receptors. Depending on their frequencies, EFs can directly activate or deactivate different groups of nuclear receptors and so determine nuclear gene expression. One of the key features of the above hypothesis is that nuclear membrane receptors, besides their own endogenous or chemical ligands (hormones, lipids, etc.), can also be activated by electromagnetic signals. Moreover, normal MMP values (about -140mV) are associated with the production of high ATP quantities and small levels of reactive oxygen species (ROS) while the hyperpolarization observed in all cancer cell types leads to a dramatic fall in ATP production and an analogous increase in ROS. The diminished ATP and increased ROS production negatively affect the function of all cellular systems including nucleus. Restoration of mitochondrial function, which is characterized by the fluctuation of MMP and EF values within a certain (normal) range, is proposed as a necessary condition for normal nuclear function and cancer therapy.
    No preview · Article · Oct 2015 · Medical Hypotheses
    • "HESC metabolism is characterized by a greater reliance on glycolysis as compared to cells in the differentiated state789. Glycolytic flux is essential for maintenance of the stem cell phenotype, as evidenced by the impact of inhibitors of glycolysis on pluripotency marker expression and cellular reprogramming [10, 11] . While glucose metabolism provides cellular energy by producing adenosine triphosphate (ATP) and reducing equivalents, glucose is also the primary carbon source for a myriad of biosynthetic precursors, including ribose for nucleotides , non-essential amino acids, and acetyl-coenzyme A (AcCoA) for lipids. "
    [Show abstract] [Hide abstract]
    ABSTRACT: To realize the potential of human embryonic stem cells (hESCs) in regenerative medicine and drug discovery applications, large numbers of cells that accurately recapitulate cell and tissue function must be robustly produced. Previous studies have suggested that genetic instability and epigenetic changes occur as a consequence of enzymatic passaging; however, the potential impacts of such passaging methods on the metabolism of hESCs have not been described. Using stable isotope tracing and mass spectrometry-based metabolomics, we have explored how different passaging reagents impact hESC metabolism. Enzymatic passaging caused significant decreases in glucose utilization throughout central carbon metabolism along with attenuated de novo lipogenesis. In addition, we developed and validated a method for rapidly quantifying glycan abundance and isotopic labeling in hydrolyzed biomass. Enzymatic passaging reagents significantly altered levels of glycans immediately after digestion but surprisingly glucose contribution to glycans was not affected. These results demonstrate that there is an immediate effect on hESC metabolism after enzymatic passaging in both central carbon metabolism and biosynthesis. HESCs subjected to enzymatic passaging are routinely placed in a state requiring re-synthesis of biomass components, subtly influencing their metabolic needs in a manner that may impact cell performance in regenerative medicine applications. Copyright © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
    No preview · Article · Aug 2015 · Biotechnology Journal
Show more